Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
Por:
Santin M, Morandeira-Rego F, Alcaide F, Rabuñal R, Anibarro L, Agüero-Balbín R, Casas X, Pérez-Escolano E, Navarro MD, Sánchez F, Coira-Nieto A, Trigo-Daporta M, Martinez-Meñaca A, Gonzalez-Cuevas MA, López-Prieto MD, Domínguez-Castellano Á and Jové N
Publicada:
1 dic 2016
Ahead of Print:
16 sep 2016
Resumen:
Previous reports have identified interleukin-2 (IL-2), quantified in the supernatants of QuantiFERON(®)-TB Gold In-tube (QFT) after 72 h of incubation, as a potential biomarker for distinguishing between latent and active tuberculosis (TB). However, its validity has not been tested in an appropriate clinical cohort.
Filiaciones:
Santin M:
Service of Infectious Diseases, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
Department of Clinical Sciences, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain
SEIMC Study Group for Mycobacterial Infections (GEIM).
Morandeira-Rego F:
Service of Immunology, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
Alcaide F:
Service of Microbiology, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain
Department of Pathology and Experimental Therapy, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain
SEIMC Study Group for Mycobacterial Infections (GEIM)
Rabuñal R:
Unit of Infectious Diseases, Hospital Universitario Lucus Augusti, Lugo, Spain
Anibarro L:
Unit of Tuberculosis, Service of Infectious Diseases-Internal Medicine, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain
Agüero-Balbín R:
Service of Respiratory Diseases, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Casas X:
Respiratory Diseases, Hospital General Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona
Pérez-Escolano E:
Unidad de Gestión Clínica Enfermedades Infecciosas y Microbiología, Hospital de Jerez, Jerez de la Frontera, Cádiz, Spain
Navarro MD:
Clinic Unit of Infectious Diseases and Preventive Medicine, Hospital Virgen Macarena, Sevilla, Spain
Sánchez F:
Service of Infectious Diseases, Institut Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
Coira-Nieto A:
Service of Microbiology, Hospital Universitario Lucus Augusti, Lugo, Spain
Trigo-Daporta M:
Service of Microbiology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain
Martinez-Meñaca A:
Service of Respiratory Diseases, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Gonzalez-Cuevas MA:
Service of Microbiology, Hospital General Parc Sanitari Sant Joan de Déu, Sant Boi, Barcelona, Spain
López-Prieto MD:
Unidad de Gestión Clínica Enfermedades Infecciosas y Microbiología, Hospital de Jerez, Jerez de la Frontera, Cádiz, Spain
Domínguez-Castellano Á:
Clinic Unit of Infectious Diseases and Preventive Medicine, Hospital Virgen Macarena, Sevilla, Spain
Jové N:
Service of Infectious Diseases, Institut Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain
Open Access
|